Early human trial begins for experimental obesity medication
NCT ID NCT07437079
Summary
This early-stage study is testing a new medication called NNC6989-0001 to see if it's safe and how it behaves in the body. The trial involves 96 healthy adults who are overweight or have obesity, who will receive either the experimental drug or a placebo. The main goal is to identify any side effects and understand how the drug moves through the body before testing whether it helps with weight management.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON Early Phase Services, LLC
RECRUITINGLenexa, Kansas, 66219, United States
Conditions
Explore the condition pages connected to this study.